385 related articles for article (PubMed ID: 34809825)
21. Modulating antibody effector functions by Fc glycoengineering.
García-Alija M; van Moer B; Sastre DE; Azzam T; Du JJ; Trastoy B; Callewaert N; Sundberg EJ; Guerin ME
Biotechnol Adv; 2023 Oct; 67():108201. PubMed ID: 37336296
[TBL] [Abstract][Full Text] [Related]
22. Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting.
Thomann M; Malik S; Kuhne F; Avenal C; Plath F; Bonnington L; Reusch D; Bulau P; Cymer F
Bioanalysis; 2019 Aug; 11(15):1437-1449. PubMed ID: 31490109
[No Abstract] [Full Text] [Related]
23. Site-specific N-glycan Analysis of Antibody-binding Fc γ Receptors from Primary Human Monocytes.
Roberts JT; Patel KR; Barb AW
Mol Cell Proteomics; 2020 Feb; 19(2):362-374. PubMed ID: 31888963
[TBL] [Abstract][Full Text] [Related]
24. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
25. A functional spleen contributes to afucosylated IgG in humans.
Wojcik I; Schmidt DE; de Neef LA; Rab MAE; Meek B; de Weerdt O; Wuhrer M; van der Schoot CE; Zwaginga JJ; de Haas M; Falck D; Vidarsson G
Sci Rep; 2021 Dec; 11(1):24045. PubMed ID: 34911982
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of
Zou G; Kosikova M; Kim SR; Kotian S; Wu WW; Shen R; Powers DN; Agarabi C; Xie H; Ju T
J Biol Chem; 2018 Dec; 293(50):19277-19289. PubMed ID: 30315103
[TBL] [Abstract][Full Text] [Related]
27. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
[TBL] [Abstract][Full Text] [Related]
28. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
[TBL] [Abstract][Full Text] [Related]
29. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma.
Pan H; Wu Z; Zhang H; Zhang J; Liu Y; Li Z; Feng W; Wang G; Liu Y; Zhao D; Zhang Z; Liu Y; Zhang Z; Liu X; Tao L; Luo Y; Wang X; Yang X; Zhang F; Li X; Guo X
Front Immunol; 2023; 14():981861. PubMed ID: 36999031
[TBL] [Abstract][Full Text] [Related]
31. Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: a molecular dynamics study.
Harbison AM; Brosnan LP; Fenlon K; Fadda E
Glycobiology; 2019 Jan; 29(1):94-103. PubMed ID: 30325416
[TBL] [Abstract][Full Text] [Related]
32. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
33. An integrated method for IgG N-glycans enrichment and analysis: Understanding the role of IgG glycosylation in diabetic foot ulcer.
Xiao Y; Dong X; Chen C; Cui Y; Chu T; Li X; Wang A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123983. PubMed ID: 38163392
[TBL] [Abstract][Full Text] [Related]
34. Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients.
Kljaković-Gašpić Batinjan M; Petrović T; Vučković F; Hadžibegović I; Radovani B; Jurin I; Đerek L; Huljev E; Markotić A; Lukšić I; Trbojević-Akmačić I; Lauc G; Gudelj I; Čivljak R
Engineering (Beijing); 2022 Sep; ():. PubMed ID: 36093331
[TBL] [Abstract][Full Text] [Related]
35. The
de Haan N; Reiding KR; Krištić J; Hipgrave Ederveen AL; Lauc G; Wuhrer M
Front Immunol; 2017; 8():608. PubMed ID: 28620376
[No Abstract] [Full Text] [Related]
36. IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age.
Twisselmann N; Bartsch YC; Pagel J; Wieg C; Hartz A; Ehlers M; Härtel C
Front Immunol; 2018; 9():3166. PubMed ID: 30713537
[TBL] [Abstract][Full Text] [Related]
37. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
38. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
39. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.
Zou G; Ochiai H; Huang W; Yang Q; Li C; Wang LX
J Am Chem Soc; 2011 Nov; 133(46):18975-91. PubMed ID: 22004528
[TBL] [Abstract][Full Text] [Related]
40. Preparation and biological activities of anti-HER2 monoclonal antibodies with multibranched complex-type N-glycans.
Takashima S; Kurogochi M; Tsukimura W; Mori M; Osumi K; Sugawara SI; Amano J; Mizuno M; Takada Y; Matsuda A
Glycobiology; 2021 Nov; 31(10):1401-1414. PubMed ID: 34192331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
